Alpha-glucosidase inhibitors

all type of patients - pdf

Angiotensin renin system blockade

all type of patients - pdf

Angiotensin-receptor blockers - candesartan - irbesartan - losartan - telmisartan - valsartan

all type of patients - pdf

Anti hypertensive agents

patients with hypertension - pdf

patients with or without hypertension - pdf

patients without hypertension - pdf

Antidiabetic drugs - albiglutide - alogliptin - canagliflozin - dapagliflozin - empagliflozin - exenatide - glipizide - glyburide - liraglutide - lixisenatide - metformin - nateglinide - nouveau - pioglitazone - rosiglitazone - saxagliptin - sitagliptin - sulfonylurea - taspoglutide - troglitazone - voglibose

patients insufficiently controlled on SU - pdf

Type 1 and 2 diabetes - pdf

patients inadequately controlled on metformin - pdf

all types of patients - pdf

Patients inadequately controlled on MET+SU therapy - pdf

Type 1 diabetes - pdf

patients with insufficient glycaemic control with bitherapy - pdf

patients inadequately controlled on monotherapy - pdf

patients inadequately controlled with insulin - pdf

in patients inadequately controlled on standard therapy - pdf

patients inadequately controlled on TZD - pdf

drug naïve patients - pdf

Antidiabetic drugs added to metformin

type 2 daibetes (NIDD) - pdf

Antioxydants - beta carotene - vitamin c - vitamin e

all type of patients - pdf

Antiplatelets drug - A EFFACER - aspirin - atopaxar - cangrelor - clopidogrel - dipyridamol - elinogrel - prasugrel - sulfinpyrazone - ticagrelor - ticlopidine - triflusal - vorapaxar

all type of patients - pdf

patients without cardiovascular disease - pdf

Antithrombotics - abciximab - apixaban - bivalirudin - coumadin - dabigatran - deltaparin - dicoumarol - edoxaban - eptifibatide - fondaparinux - fraxiparin - heparin - hirudin - idraparinux - reviparin - rivaroxaban - tirofiban - UFH - wafarine - warfarin - ximelagatran

patient without history of atherosclerotic disease - pdf

Cholesterol lowering intervention - atorvastatin - bezafibrate - cerivastatin - cholestyramine - clofibrate - colestipol - diet - etofibrate - ezetimibe - fenofibrate - fluvastatin - gemfibrozil - lovastatin - niacin - policosanol - pravastatin - probucol - rosuvastatin - simvastatin

diabetic patients with or withour hypercholesterolemia - pdf

Glucose lowering for cardiovascular prevention

all type of patients - pdf

meta-regression - pdf

Insulin secretagogues - glimeripide - linagliptin - mitiglinide - repaglinide

all type of patients - pdf

Insulin secretagogues - DPP-4 inhibitors

all types of patients - pdf

Insulin secretagogues - Meglitinides (glinides)

all types of patients - pdf

Insulin secretagogues - sulfonylureas

all type of patients - pdf

Insulin secretagogues peptides (incretins)

obese individuals - pdf

all type of patients - pdf

Insulin sensitizer

all type of patients - pdf

patients with cardiovascular disease - pdf

Insulin sensitizer - biguanides

all type of patients - pdf

Insulin sensitizers - glitazones

all type of patients - pdf

patients with cardiovascular disease - pdf

Insulin sensitizers - PPAR modulator

all types of patients - pdf

Insulin therapy

all type of patients - pdf

Intensive glycemic control

Type 1 and 2 diabetes - pdf

type 2 diabetes (NIDD) - pdf

Type 1 diabetes - pdf

Intensive therapy

all type of patients - pdf

Prevention

people with impaired glucose tolerance - pdf

all type of patients - pdf

Screening for CAD

all type of patients - pdf

SGLT2 inhibitors - dapagliflozin - empagliflozin

all type of patients - pdf

Weight-loss drugs - orlistat

all type of diabetics - pdf